Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (471-480 of 504) with videos related to

Pageof 51
Sort By:
Leukemia|April 15, 2020
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL studyMassimo Gentile, Fortunato Morabito, Giovanni Del Poeta, et al.
Leukemia|July 8, 2025
Integration of [<sup>18</sup>F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphomaRiccardo Dondolin, Federico Garrou, Mohammad Almasri, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Nature Immunology|June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesisBerenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Hemasphere|February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformationChiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Strategies for the transfusion of subjects with complex red cell immunisation: the Bank of rare blood donors of the Region of LombardyFernanda Morelati, Piera Arnaboldi, Fiorella Barocci, et al.
American Journal of Hematology|February 13, 2021
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL studyFortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Pageof 51

Showing results (471-480 of 504) with videos related to

Sort By:
Pageof 51
Leukemia|April 15, 2020
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL studyMassimo Gentile, Fortunato Morabito, Giovanni Del Poeta, et al.
Leukemia|July 8, 2025
Integration of [<sup>18</sup>F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphomaRiccardo Dondolin, Federico Garrou, Mohammad Almasri, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Nature Immunology|June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesisBerenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Hemasphere|February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformationChiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Strategies for the transfusion of subjects with complex red cell immunisation: the Bank of rare blood donors of the Region of LombardyFernanda Morelati, Piera Arnaboldi, Fiorella Barocci, et al.
American Journal of Hematology|February 13, 2021
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL studyFortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Pageof 51